Top compounds associated with response to GIMD1


Feature Type Standardized
Nominal ANOVA
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.0092 0.8
mRNA QS11 CTRPv2 pan-cancer AAC -0.02 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.009 0.8
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0089 0.8
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.0081 0.8
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA CID-5951923 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.0081 0.8
mRNA AZD8055 CTRPv2 pan-cancer AAC 0.0095 0.8
mRNA Repligen 136 CTRPv2 pan-cancer AAC -0.0099 0.8
Download CSV